Clinical Trial Update: Study on Interleukin-7 (CYT107) in HIV Patients [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating interleukin-7 (CYT107) in HIV patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• CYT107 (CYT107)

Snippet

Sponsor: Cytheris SA | Conditions: HIV | Phase 2 | Status: TERMINATED